poisar

Stocks · News reference

Genprex Reports REQORSA Analysis Showing Shift Toward Cellular Maintenance

Fiscal.ai

Genprex announced new research findings from an analysis of blood samples from lung cancer patients treated with REQORSA, revealing shifts in gene expression related to cellular maintenance and repair.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Genprex, Inc. (GNPX)

    Filed: 2026-11-04 AccNo: 0001437749-26-034764 Size: 172 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits